Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N F Smith

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Clinical Pharmacology and Therapeutics|December 23, 2006
Variants in the SLCO1B3 gene: interethnic distribution and association with paclitaxel pharmacokineticsN F Smith, S Marsh, T J Scott-Horton, et al.
Substance Use & Misuse|April 21, 1998
Computer-based smoking cessation interventions in adolescents: description, feasibility, and six-month follow-up findingsU E Pallonen, W F Velicer, J O Prochaska, et al.
British Journal of Cancer|October 27, 2005
Preclinical pharmacokinetics and metabolism of a novel prototype DNA-PK inhibitor NU7026B P Nutley, N F Smith, A Hayes, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Clinical Pharmacology and Therapeutics|December 23, 2006
Variants in the SLCO1B3 gene: interethnic distribution and association with paclitaxel pharmacokineticsN F Smith, S Marsh, T J Scott-Horton, et al.
Substance Use & Misuse|April 21, 1998
Computer-based smoking cessation interventions in adolescents: description, feasibility, and six-month follow-up findingsU E Pallonen, W F Velicer, J O Prochaska, et al.
British Journal of Cancer|October 27, 2005
Preclinical pharmacokinetics and metabolism of a novel prototype DNA-PK inhibitor NU7026B P Nutley, N F Smith, A Hayes, et al.
Pageof 2